top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Drugs
Anticancer Drugs
Autore O’Boyle Niamh M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (214 p.)
Soggetto non controllato graphene oxide
indole
androgens
cyclooxygenase-2
cyclooxygenase-1
heteropolysaccharide
drug conjugation
drug delivery
ellipticine
chemical linker
oesophageal cancer
antiproliferative activity
topoisomerase II
?-lactam
DSD
antibody
topoisomerase inhibitors
magnetic targeting
cisplatin resistance
steroidogenesis
[18F]FDG PET/CT
heterocyclic chemistry
dehydroepiandrosterone
antimitotic
3-vinylazetidin-2-ones
glioblastoma
and cancer therapy
intestinal mucositis
Combretastatin A-4
metabolism
anti-cancer drugs
maghemite
COX-1 inhibitor
anticancer
CYP17A1
conjugate and hybrid drugs
inflammation
snticancer drugs
P450c17
tumorigenesis
cisplatin
biomarker profiling
cancer drug design
tubulin
cytochrome P450
5-fluorouracil
prostate cancer
abiraterone
NCI screen
radiation
cancer immunotherapy
microtubule targeted drugs
cancer
treatment resistance
ISBN 3-03921-587-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367753903321
O’Boyle Niamh M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (594 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato thymidylate synthase
cytotoxicity
1,2,3-triazole
1,3,4-oxadiazole
5-fluoruracil
pemetrexed
docking
3,4'-bis-guanidino
3-amino-4'-guanidino
diphenyl ether
phenyl pyridyl ether
intramolecular hydrogen bond
cancer cell viability
HL-60
BRAF
apoptosis
thieno[2,3-d][1,2,3]triazine
acetamide
H1299
HER2
EGFR
Bcl-2 inhibitors
Indole-based analogues
benzimidazole
MTT cytotoxic assay
cell cycle analysis
DNA fragmentation
ELISA
solid/lipid nanoparticles
phenstatin
letrozole
tubulin polymerisation inhibitor
aromatase inhibitor
breast cancer
hybrid molecule
dual-targeting molecule
designed multiple ligand
NaMSA
cyclophosphamide
histopathology
testis
urinary bladder
anticancer agents
enantioselective synthesis
gastric adenocarcinoma
tryptophanol
concentration-guided dosing
model informed dosing
physiologically based pharmacokinetics
sorafenib
tyrosil-DNA-phosphodiesterase 1
adamantane
resin acid
TDP1
cytotoxic agents
apoptosis induction
HT-29 cells
MDA-MB-231 cells
mechanism prediction
STAT inhibitors
miR-21
hydrazide derivatives
nitrogen scaffolds
mitoxantrone
cardiotoxicity
inflammation
oxidative stress
age
cumulative dose
Trk
NTRK
tissue-agnostic
larotrectinib
entrectinib
Trk fusion
protein kinase inhibitors
USFDA
cancer
patent review
generic product
doxazosin
MD simulations
combretastatin A-4
cytotoxic activity
hybrid compounds
indazole
mucin
MUC1
MUC16
immunotherapy
cancer vaccine
CAR (chimeric antigen receptor)
ADC (antibody-drug conjugate)
thiourea
interleukin-6
trypan blue assay
chalcones
exportin-1
covalent binding
CovDock
anticancer activity
xanthone
in vitro
in vivo
isolation
synthesis
heterocyclic compound
benzenesulfonamides
imidazoles
alkylated
colony formation
tumor spheroids
HDAC inhibitors
chalcone
dual inhibitors
carvedilol
kidney
toxicity
7-deaza-4'-thioadenosine derivatives
multi-kinase inhibitor
anticancer
nucleoside
Imiquimod
drug efflux
multidrug resistance
Toll-Like Receptor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui